The value of 99mTc-tetrofosmin brain SPECT in predicting survival in patients with glioblastoma multiforme (Journal article)

Alexiou, G. A./ Tsiouris, S./ Kyritsis, A. P./ Fotakopoulos, G./ Goussia, A./ Voulgaris, S./ Fotopoulos, A. D.

Full metadata record
DC FieldValueLanguage
dc.contributor.authorAlexiou, G. A.en
dc.contributor.authorTsiouris, S.en
dc.contributor.authorKyritsis, A. P.en
dc.contributor.authorFotakopoulos, G.en
dc.contributor.authorGoussia, A.en
dc.contributor.authorVoulgaris, S.en
dc.contributor.authorFotopoulos, A. D.en
dc.date.accessioned2015-11-24T19:20:14Z-
dc.date.available2015-11-24T19:20:14Z-
dc.identifier.issn1535-5667-
dc.identifier.urihttps://olympias.lib.uoi.gr/jspui/handle/123456789/22020-
dc.rightsDefault Licence-
dc.subjectAgeden
dc.subjectBrain/*radionuclide imagingen
dc.subjectBrain Neoplasms/*radionuclide imaging/*therapyen
dc.subjectFemaleen
dc.subjectFlow Cytometryen
dc.subjectGlioblastoma/*radionuclide imaging/*therapyen
dc.subjectHumansen
dc.subjectImage Interpretation, Computer-Assisteden
dc.subjectImmunohistochemistryen
dc.subjectKaplan-Meier Estimateen
dc.subjectKarnofsky Performance Statusen
dc.subjectKi-67 Antigen/analysisen
dc.subjectMaleen
dc.subjectMiddle Ageden
dc.subjectOrganophosphorus Compounds/*diagnostic useen
dc.subjectOrganotechnetium Compounds/*diagnostic useen
dc.subjectPredictive Value of Testsen
dc.subjectRadiopharmaceuticals/*diagnostic useen
dc.subjectSurvival Analysisen
dc.subjectTomography, Emission-Computed, Single-Photonen
dc.titleThe value of 99mTc-tetrofosmin brain SPECT in predicting survival in patients with glioblastoma multiformeen
heal.typejournalArticle-
heal.type.enJournal articleen
heal.type.elΆρθρο Περιοδικούel
heal.identifier.primary10.2967/jnumed.110.080929-
heal.identifier.secondaryhttp://www.ncbi.nlm.nih.gov/pubmed/21078797-
heal.identifier.secondaryhttp://jnm.snmjournals.org/content/51/12/1923.full.pdf-
heal.languageen-
heal.accesscampus-
heal.recordProviderΠανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικήςel
heal.publicationDate2010-
heal.abstract(99m)Tc-tetrofosmin brain SPECT has been reported as a useful tool for the evaluation of glioma proliferation. In the present study, we set out to investigate the prognostic value of (99m)Tc-tetrofosmin brain SPECT in patients with glioblastoma multiforme. METHODS: We prospectively studied 18 patients (13 men, 5 women; mean age +/- SD, 60.8 +/- 7.79 y) who were operated on for glioblastoma multiforme. All patients underwent preoperative (99m)Tc-tetrofosmin brain SPECT, and surgical excision was performed within a week after SPECT. All patients received postoperative radiotherapy and chemotherapy. RESULTS: By calculating the lesion-to-normal (L/N) (99m)Tc-tetrofosmin uptake ratio, we found that patients with an L/N ratio of more than 4.7 had significantly worse survival than did patients with an L/N ratio of 4.7 or less. Furthermore, patients with a Karnofsky Performance Score more than 90 had a significantly better survival rate. Although patients with near-total tumor resection who were younger than 60 y survived longer, the difference did not reach statistical significance. In the multivariate analysis, (99m)Tc-tetrofosmin uptake and Karnofsky Performance Score were identified as factors with independent prognostic power. CONCLUSION: (99m)Tc-tetrofosmin brain SPECT may be an independent prognostic factor in patients with glioblastoma multiforme. Further larger studies are needed to verify these results.en
heal.journalNameJ Nucl Meden
heal.journalTypepeer-reviewed-
heal.fullTextAvailabilityTRUE-
Appears in Collections:Άρθρα σε επιστημονικά περιοδικά ( Ανοικτά)

Files in This Item:
File Description SizeFormat 
Alexiou-2010-The value of 99mTc-t.pdf174.72 kBAdobe PDFView/Open    Request a copy


 Please use this identifier to cite or link to this item:
https://olympias.lib.uoi.gr/jspui/handle/123456789/22020
  This item is a favorite for 0 people.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.